Literature DB >> 21724574

MR imaging of parotid tumors: typical lesion characteristics in MR imaging improve discrimination between benign and malignant disease.

A Christe1, C Waldherr, R Hallett, P Zbaeren, H Thoeny.   

Abstract

BACKGROUND AND
PURPOSE: The surgical approach to parotid tumors is different for benign and malignant neoplasms, but the clinical symptoms do not correlate well with histology. Difficulties in tumor classification also arise in imaging modalities, in which sonography has the lowest and MR imaging, the highest accuracy. The purpose of this study was to review our experience using conventional MR imaging of the neck in the evaluation of parotid tumors and to evaluate which MR imaging findings are best able to predict malignant histology.
MATERIALS AND METHODS: Eighty-four consecutive patients (43 males, 41 females; median age, 56 years; range, 9-85 years) with parotid gland tumors who underwent MR imaging before surgery were prospectively included in the present study and retrospectively analyzed. Histology was available for all tumors. We analyzed the following MR imaging parameters: signal intensity, contrast enhancement, lesion margins (well-defined versus ill-defined), lesion location (deep/superficial lobe), growth pattern (focal, multifocal, or diffuse), and extension into neighboring structures, perineural spread, and lymphadenopathy.
RESULTS: The 57 (68%) benign and 27 (32%) malignant tumors consisted of 29 pleomorphic adenomas, 17 Warthin tumors, 11 various benign tumors, 5 mucoepidermoid carcinomas, 3 adenoid cystic carcinomas, 1 acinic cell carcinoma, 1 carcinoma ex pleomorphic adenoma, 9 metastases, and 8 various malignant neoplasms. Specific signs predictive of malignancy were the following: T2 hypointensity of the parotid tumor (P = .048), ill-defined margins (P = .001), diffuse growth (P = .012), infiltration of subcutaneous tissue (P = .0034), and lymphadenopathy (P = .012).
CONCLUSIONS: Low signal intensity on T2-weighted images and postcontrast ill-defined margins of a parotid tumor are highly suggestive of malignancy.

Entities:  

Mesh:

Year:  2011        PMID: 21724574      PMCID: PMC7966029          DOI: 10.3174/ajnr.A2520

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  31 in total

Review 1.  Major salivary gland imaging.

Authors:  D M Yousem; M A Kraut; A A Chalian
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

2.  Hemangiopericytoma of the parotid gland: CT and MR features.

Authors:  B Mortelé; M Lemmerling; P Seynaeve; P Clarysse; F Quintens; M Kunnen
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 3.  Swelling at the angle of the mandible: imaging of the pediatric parotid gland and periparotid region.

Authors:  L H Lowe; L S Stokes; J E Johnson; R M Heller; S A Royal; C Wushensky; M Hernanz-Schulman
Journal:  Radiographics       Date:  2001 Sep-Oct       Impact factor: 5.333

4.  Parotid gland: plain and gadolinium-enhanced MR imaging.

Authors:  T J Vogl; S H Dresel; M Späth; G Grevers; C Wilimzig; H K Schedel; J Lissner
Journal:  Radiology       Date:  1990-12       Impact factor: 11.105

5.  Use of cross-sectional imaging in predicting surgical location of parotid neoplasms.

Authors:  Vasu Divi; Michael A Fatt; Theodoros N Teknos; Suresh K Mukherji
Journal:  J Comput Assist Tomogr       Date:  2005 May-Jun       Impact factor: 1.826

6.  MR imaging of parotid mass lesions: attempts at histopathologic differentiation.

Authors:  J D Swartz; M I Rothman; F I Marlowe; A S Berger
Journal:  J Comput Assist Tomogr       Date:  1989 Sep-Oct       Impact factor: 1.826

7.  MR of intraparotid masses.

Authors:  B N Schlakman; D M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  1993 Sep-Oct       Impact factor: 3.825

8.  Characteristic bright signal of parotid pleomorphic adenomas on T2-weighted MR images with pathological correlation.

Authors:  Y Tsushima; M Matsumoto; K Endo; T Aihara; T Nakajima
Journal:  Clin Radiol       Date:  1994-07       Impact factor: 2.350

9.  Parotid masses: MR imaging.

Authors:  L M Teresi; R B Lufkin; D G Wortham; E Abemayor; W N Hanafee
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

10.  Malignant parotid tumors: clinical use of MR imaging and histologic correlation.

Authors:  N J Freling; W M Molenaar; A Vermey; E L Mooyaart; A K Panders; A A Annyas; C J Thijn
Journal:  Radiology       Date:  1992-12       Impact factor: 11.105

View more
  46 in total

1.  Sonoelastography of parotid gland tumours: initial experience and identification of characteristic patterns.

Authors:  Nils Klintworth; Konstantinos Mantsopoulos; Johannes Zenk; Georgios Psychogios; Heinrich Iro; Alessandro Bozzato
Journal:  Eur Radiol       Date:  2012-01-22       Impact factor: 5.315

2.  Metastases to the parotid nodes: CT and MR imaging findings.

Authors:  Nobuo Kashiwagi; Takamichi Murakami; Masafumi Toguchi; Katsuyuki Nakanishi; Shojiro Hidaka; Hideyuki Fukui; Masatomo Kimura; Mutsukazu Kitano; Noriyuki Tomiyama
Journal:  Dentomaxillofac Radiol       Date:  2016-10-11       Impact factor: 2.419

3.  Intraparotid facial nerve schwannoma: A case report.

Authors:  Abhishek Jaiswal; Asit Ranjan Mridha; Devajit Nath; Ashu Seith Bhalla; Alok Thakkar
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 4.  Contrast-enhanced ultrasound in the evaluation of parotid gland lesions: an update of the literature.

Authors:  E David; V Cantisani; M De Vincentiis; P S Sidhu; A Greco; M Tombolini; F M Drudi; D Messineo; S Gigli; A Rubini; D Fresilli; D Ferrari; F Flammia; F D'Ambrosio
Journal:  Ultrasound       Date:  2016-01-27

5.  Assessment of salivary gland tumors using MRI and CT: impact of experience on diagnostic accuracy.

Authors:  Thomas J Vogl; Moritz H Albrecht; Nour-El-Din A Nour-Eldin; Hanns Ackermann; Adel Maataoui; Timo Stöver; Matthew W Bickford; Tatjana Stark-Paulsen
Journal:  Radiol Med       Date:  2017-09-25       Impact factor: 3.469

Review 6.  Clinical utility of dynamic-enhanced MRI in salivary gland tumors: retrospective study and literature review.

Authors:  Takenori Ogawa; Ikuho Kojima; Ryo Ishii; Maya Sakamoto; Takaki Murata; Takahiro Suzuki; Kengo Kato; Ayako Nakanome; Akira Ohkoshi; Eiichi Ishida; Seiji Kakehata; Kiyoto Shiga; Yukio Katori
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-06       Impact factor: 2.503

7.  Non-enhanced MRI in combination with color Doppler flow imaging for improving diagnostic accuracy of parotid gland lesions.

Authors:  Wei Zhang; Zhichao Zuo; Ningbin Luo; Lianfeng Liu; Guanqiao Jin; Junjie Liu; Danke Su
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-02-12       Impact factor: 2.503

8.  Perfusion imaging of parotid gland tumours: usefulness of arterial spin labeling for differentiating Warthin's tumours.

Authors:  Hiroki Kato; Masayuki Kanematsu; Haruo Watanabe; Kimihiro Kajita; Keisuke Mizuta; Mitsuhiro Aoki; Tomoyuki Okuaki
Journal:  Eur Radiol       Date:  2015-04-29       Impact factor: 5.315

9.  Magnetic resonance image biomarkers improve differentiation of benign and malignant parotid tumors through diagnostic model analysis.

Authors:  Yuebo Liu; Jiabao Zheng; Jizhi Zhao; Lijiang Yu; Xiaoping Lu; Zhihui Zhu; Chunlan Guo; Tao Zhang
Journal:  Oral Radiol       Date:  2021-01-11       Impact factor: 1.852

Review 10.  Cystic lesions of the parotid gland: radiologic-pathologic correlation according to the latest World Health Organization 2017 Classification of Head and Neck Tumours.

Authors:  Hirotaka Takita; Tohru Takeshita; Taro Shimono; Hiroko Tanaka; Hiroyoshi Iguchi; Shigeo Hashimoto; Yuko Kuwae; Masahiko Ohsawa; Yukio Miki
Journal:  Jpn J Radiol       Date:  2017-08-23       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.